Respiri - First patient enrolled in the US RPM programme
Respiri has announced that the first patients have been enrolled in its wheezo remote patient monitoring (RPM) programme in the United States....
62 Views
Respiri - Focus on cost optimisation
To support an optimal roll-out of its US commercialisation strategy for its wheezo device, Respiri recently announced several cost-saving...
678 Views
Respiri - Objective measures for better outcomes
Respiri is an Australian medical device and software-as-a-service (SaaS) company, developing a novel remote patient monitoring approach to...
677 Views
Respiri - NIHR funding to seek better outcomes
Respiri has received a £2m grant from the UK National Institute for Health Research (NIHR) to initiate a clinical study (TEAM-care) for wheezo, its...
669 Views
Taxing Times For Australia
The Government's release of Re:think, its tax discussion paper, is a welcome development, designed to kick-start the conversation with the...
5.8k Views